2023 annual financial data
Valion Bio, Inc. 2023 Operating margin
Valion Bio, Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was -701.11%.
Operating income was -8,245,000 USD and net income was -8,244,000 USD.
Operating cash flow was -8,511,000 USD.
Get free Valion Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,176,000 USD
- Operating income
- -8,245,000 USD
- Net income
- -8,244,000 USD
- Operating cash flow
- -8,511,000 USD